Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 373

1.

Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.

Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH, Cho ER, Kim J, Abnet CC, Tsugane S, Cai Q, Zheng W, Pawlita M, Shu XO, Epplein M.

Dig Dis Sci. 2018 Jun 8. doi: 10.1007/s10620-018-5154-9. [Epub ahead of print]

PMID:
29948559
2.

Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania.

Ursu RG, Danciu M, Spiridon IA, Ridder R, Rehm S, Maffini F, McKay-Chopin S, Carreira C, Lucas E, Costan VV, Popescu E, Cobzeanu B, Ghetu N, Iancu LS, Tommasino M, Pawlita M, Holzinger D, Gheit T.

PLoS One. 2018 Jun 25;13(6):e0199663. doi: 10.1371/journal.pone.0199663. eCollection 2018.

3.

Depressive symptoms in relation to overall survival in people with head and neck cancer: a longitudinal cohort study.

Jansen F, Verdonck-de Leeuw IM, Cuijpers P, Leemans CR, Waterboer T, Pawlita M, Penfold C, Thomas SJ, Waylen A, Ness AR.

Psychooncology. 2018 Jun 21. doi: 10.1002/pon.4816. [Epub ahead of print]

PMID:
29927013
4.

Predictors of oropharyngeal cancer survival in Europe.

Anantharaman D, Billot A, Waterboer T, Gheit T, Abedi-Ardekani B, Lagiou P, Lagiou A, Ahrens W, Holcátová I, Merletti F, Kjaerheim K, Polesel J, Simonato L, Alemany L, Mena Cervigon M, Macfarlane TV, Znaor A, Thomson PJ, Robinson M, Canova C, Conway DI, Wright S, Healy CM, Toner ME, Pawlita M, Tommasino M, Brennan P.

Oral Oncol. 2018 Jun;81:89-94. doi: 10.1016/j.oraloncology.2018.04.016. Epub 2018 May 2.

PMID:
29884419
5.

Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial.

Michels J, Becker N, Suciu S, Kaiser I, Benner A, Kosaloglu-Yalcin Z, Agoussi S, Halama N, Pawlita M, Waterboer T, Eichmüller SB, Jäger D, Eggermont AMM, Zörnig I.

Oncoimmunology. 2018 Feb 12;7(6):e1428157. doi: 10.1080/2162402X.2018.1428157. eCollection 2018.

6.

Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, Woodhall SC, Pawlita M, Wentzensen N.

J Natl Cancer Inst. 2018 May 21. doi: 10.1093/jnci/djy084. [Epub ahead of print]

PMID:
29790947
7.

Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression.

Hufnagel K, Lueong S, Willhauck-Fleckenstein M, Hotz-Wagenblatt A, Miao B, Bauer A, Michel A, Butt J, Pawlita M, Hoheisel JD, Waterboer T.

Sci Rep. 2018 May 14;8(1):7503. doi: 10.1038/s41598-018-25918-3.

8.

Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancer.

Beynon RA, Lang S, Schimansky S, Penfold CM, Waylen A, Thomas SJ, Pawlita M, Tim Waterboer, Martin RM, May M, Ness AR.

Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31416. [Epub ahead of print]

PMID:
29607493
9.

Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in India.

Bhatla N, Nene BM, Joshi S, Esmy PO, Poli URR, Joshi G, Verma Y, Zomawia E, Pimple S, Prabhu PR, Basu P, Muwonge R, Hingmire S, Sauvaget C, Lucas E, Pawlita M, Gheit T, Jayant K, Malvi SG, Siddiqi M, Michel A, Butt J, Sankaran S, Kannan TPRA, Varghese R, Divate U, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Kriplani A, Mishra G, Jadhav R, Thorat R, Tommasino M, Pillai MR, Sankaranarayanan R; Indian HPV vaccine study group.

Papillomavirus Res. 2018 Jun;5:163-171. doi: 10.1016/j.pvr.2018.03.008. Epub 2018 Mar 22.

10.

Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.

Bassig BA, Willhauck-Fleckenstein M, Shu XO, Koh WP, Gao YT, Purdue MP, Xiang YB, Adams-Haduch J, Wang R, Brenner N, Waterboer T, Michel A, Ji BT, Hosgood HD, Rabkin CS, Yang G, Wong JYY, Zhang J, Hu W, Seow WJ, Chow WH, Pawlita M, Zheng W, Yuan JM, Lan Q, Rothman N.

Int J Cancer. 2018 Aug 1;143(3):570-579. doi: 10.1002/ijc.31385. Epub 2018 Apr 6.

PMID:
29574937
11.

Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.

Sankaranarayanan R, Joshi S, Muwonge R, Esmy PO, Basu P, Prabhu P, Bhatla N, Nene BM, Shaw J, Poli URR, Verma Y, Zomawia E, Pimple S, Tommasino M, Pawlita M, Gheit T, Waterboer T, Sehr P, Pillai MR; Indian HPV vaccine study group.

Vaccine. 2018 Aug 6;36(32 Pt A):4783-4791. doi: 10.1016/j.vaccine.2018.02.087. Epub 2018 Mar 15.

12.

Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research.

Kreimer AR, Shiels MS, Fakhry C, Johansson M, Pawlita M, Brennan P, Hildesheim A, Waterboer T.

Cancer. 2018 May 1;124(9):1859-1866. doi: 10.1002/cncr.31256. Epub 2018 Mar 2. No abstract available.

PMID:
29499070
13.

Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients.

Mena M, Taberna M, Tous S, Marquez S, Clavero O, Quiros B, Lloveras B, Alejo M, Leon X, Quer M, Bagué S, Mesia R, Nogués J, Gomà M, Aguila A, Bonfill T, Blazquez C, Guix M, Hijano R, Torres M, Holzinger D, Pawlita M, Pavon MA, Bravo IG, de Sanjosé S, Bosch FX, Alemany L.

Oral Oncol. 2018 Mar;78:137-144. doi: 10.1016/j.oraloncology.2018.01.010. Epub 2018 Feb 20.

PMID:
29496041
14.

Is early life exposure to polyomaviruses and herpesviruses associated with obesity indices and metabolic traits in childhood?

Karachaliou M, de Sanjose S, Waterboer T, Roumeliotaki T, Vassilaki M, Sarri K, Leventakou V, Vafeiadi M, Chalkiadaki G, Stiakaki E, Michel A, Pawlita M, Kogevinas M, Chatzi L.

Int J Obes (Lond). 2018 Jan 30. doi: 10.1038/s41366-018-0017-1. [Epub ahead of print]

PMID:
29445241
15.

Prevalence and stability of antibodies to thirteen polyomaviruses and association with cutaneous squamous cell carcinoma: A population-based study.

Antonsson A, Neale RE, O'Rourke P, Wockner L, Michel A, Pawlita M, Waterboer T, Green AC.

J Clin Virol. 2018 Apr;101:34-37. doi: 10.1016/j.jcv.2018.01.013. Epub 2018 Jan 31.

PMID:
29414185
16.

Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.

Butt J, Jenab M, Willhauck-Fleckenstein M, Michel A, Pawlita M, Kyrø C, Tjønneland A, Boutron-Ruault MC, Carbonnel F, Severi G, Kaaks R, Kühn T, Boeing H, Trichopoulou A, la Vecchia C, Karakatsani A, Panico S, Tumino R, Agnoli C, Palli D, Sacerdote C, Bueno-de-Mesquita HBA, Weiderpass E, Sánchez MJ, Bonet Bonet C, Huerta JM, Ardanaz E, Bradbury K, Gunter M, Murphy N, Freisling H, Riboli E, Tsilidis K, Aune D, Waterboer T, Hughes DJ.

Int J Cancer. 2018 Jul 15;143(2):245-252. doi: 10.1002/ijc.31283. Epub 2018 Feb 14.

PMID:
29377173
17.

Antibody response to polyomavirus primary infection: high seroprevalence of Merkel cell polyomavirus and lymphoid tissue involvement.

Cason C, Monasta L, Zanotta N, Campisciano G, Maestri I, Tommasino M, Pawlita M, Villani S, Comar M, Delbue S.

J Neurovirol. 2018 Jun;24(3):314-322. doi: 10.1007/s13365-017-0612-2. Epub 2018 Jan 12.

PMID:
29330826
18.

Helicobacter pylori Blood Biomarkers and Gastric Cancer Survival in China.

Varga MG, Wang T, Cai H, Xiang YB, Gao YT, Ji BT, Pawlita M, Waterboer T, Zheng W, Shu XO, Epplein M.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):342-344. doi: 10.1158/1055-9965.EPI-17-1084. Epub 2017 Dec 20.

PMID:
29263184
19.

Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer.

Teras LR, Gapstur SM, Maliniak ML, Jacobs EJ, Gansler T, Michel A, Pawlita M, Waterboer T, Campbell PT.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):219-223. doi: 10.1158/1055-9965.EPI-17-0407. Epub 2017 Dec 18.

PMID:
29254936
20.

Cutaneous HPV and alpha-mucosal 9-valent HPV sero-status associations.

Rahman S, Giuliano AR, Rollison DE, Pawlita M, Waterboer T, Villa LL, Lazcano Ponce E.

Papillomavirus Res. 2017 Dec;4:54-57. doi: 10.1016/j.pvr.2017.08.001. Epub 2017 Aug 2.

21.

Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.

Schroeder L, Wichmann G, Willner M, Michel A, Wiesenfarth M, Flechtenmacher C, Gradistanac T, Pawlita M, Dietz A, Waterboer T, Holzinger D.

Int J Cancer. 2018 Apr 1;142(7):1361-1368. doi: 10.1002/ijc.31167. Epub 2017 Dec 4.

PMID:
29159804
22.

Smoking and subsequent human papillomavirus infection: a mediation analysis.

Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N.

Ann Epidemiol. 2017 Nov;27(11):724-730.e1. doi: 10.1016/j.annepidem.2017.10.004. Epub 2017 Oct 17.

PMID:
29107447
23.

Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.

Schmidt K, Butt J, Mauter P, Vogel K, Erles-Kemna A, Pawlita M, Nicklas W.

PLoS One. 2017 Oct 31;12(10):e0187174. doi: 10.1371/journal.pone.0187174. eCollection 2017.

24.

Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy.

Baboci L, Holzinger D, Boscolo-Rizzo P, Tirelli G, Spinato R, Lupato V, Fuson R, Schmitt M, Michel A, Halec G, Da Mosto MC, Pawlita M, Del Mistro A.

Papillomavirus Res. 2016 Dec;2:133-140. doi: 10.1016/j.pvr.2016.07.002. Epub 2016 Jul 16.

25.

Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.

Mena M, Lloveras B, Tous S, Bogers J, Maffini F, Gangane N, Kumar RV, Somanathan T, Lucas E, Anantharaman D, Gheit T, Castellsagué X, Pawlita M, de Sanjosé S, Alemany L, Tommasino M; HPV-AHEAD study group.

PLoS One. 2017 Oct 16;12(10):e0184520. doi: 10.1371/journal.pone.0184520. eCollection 2017.

26.

Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study.

Bouwes Bavinck JN, Feltkamp MCW, Green AC, Fiocco M, Euvrard S, Harwood CA, Nasir S, Thomson J, Proby CM, Naldi L, Diphoorn JCD, Venturuzzo A, Tessari G, Nindl I, Sampogna F, Abeni D, Neale RE, Goeman JJ, Quint KD, Halk AB, Sneek C, Genders RE, de Koning MNC, Quint WGV, Wieland U, Weissenborn S, Waterboer T, Pawlita M, Pfister H; EPI-HPV-UV-CA group.

Am J Transplant. 2018 May;18(5):1220-1230. doi: 10.1111/ajt.14537. Epub 2017 Nov 22.

27.

Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.

Lang Kuhs KA, Kreimer AR, Trivedi S, Holzinger D, Pawlita M, Pfeiffer RM, Gibson SP, Schmitt NC, Hildesheim A, Waterboer T, Ferris RL.

Cancer. 2017 Nov 15;123(22):4382-4390. doi: 10.1002/cncr.30966. Epub 2017 Sep 26.

PMID:
28950407
28.

Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.

Fernández de Larrea-Baz N, Pérez-Gómez B, Michel A, Romero B, Lope V, Pawlita M, Fernández-Villa T, Moreno V, Martín V, Willhauck-Fleckenstein M, López-Abente G, Castilla J, Fernández-Tardón G, Dierssen-Sotos T, Santibáñez M, Peiró R, Jiménez-Moleón JJ, Navarro C, Castaño-Vinyals G, Kogevinas M, Pollán M, de Sanjosé S, Del Campo R, Waterboer T, Aragonés N.

Cancer Epidemiol. 2017 Oct;50(Pt A):76-84. doi: 10.1016/j.canep.2017.08.002. Epub 2017 Sep 7.

PMID:
28888185
29.

"Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1,594 cases".

Rakislova N, Clavero O, Alemany L, Saco A, Quirós B, Lloveras B, Alejo M, Pawlita M, Quint W, Del Pino M, de Sanjose S, Ordi J; VVAP study group.

Int J Cancer. 2017 Dec 15;141(12):2517-2527. doi: 10.1002/ijc.31006. Epub 2017 Aug 31.

PMID:
28815579
30.

Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013.

Fernández-de-Larrea N, Michel A, Romero B, Butt J, Pawlita M, Pérez-Gómez B, Castaño-Vinyals G, Moreno V, Martín V, Amiano P, Castilla J, Fernández-Tardón G, Dierssen-Sotos T, Clofent J, Alguacil J, Huerta JM, Jiménez-Moleón JJ, Barricarte A, Molinuevo A, Fernández-Villa T, Casabonne D, Sierra Á, Kogevinas M, de Sanjosé S, Pollán M, Del Campo R, Waterboer T, Aragonés N.

Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12401. Epub 2017 Jul 24.

PMID:
28737284
31.

Concordance of HPV load and HPV mRNA for 16 carcinogenic/possibly carcinogenic HPV types in paired smear/tissue cervical cancer specimens.

Halec G, Dondog B, Pawlita M, Schmitt M.

Arch Virol. 2017 Nov;162(11):3313-3327. doi: 10.1007/s00705-017-3452-8. Epub 2017 Jul 17.

PMID:
28717857
32.

Helicobacter pylori Seropositivity and Childhood Neurodevelopment, the Rhea Birth Cohort in Crete, Greece.

Karachaliou M, Chatzi L, Michel A, Kyriklaki A, Kampouri M, Koutra K, Roumeliotaki T, Chalkiadaki G, Stiakaki E, Pawlita M, Waterboer T, Kogevinas M, de Sanjose S.

Paediatr Perinat Epidemiol. 2017 Jul;31(4):374-384. doi: 10.1111/ppe.12374. Epub 2017 Jun 22.

PMID:
28640520
33.

Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer.

Broglie MA, Jochum W, Michel A, Waterboer T, Foerbs D, Schoenegg R, Stoeckli SJ, Pawlita M, Holzinger D.

Oral Oncol. 2017 Jul;70:43-50. doi: 10.1016/j.oraloncology.2017.05.010. Epub 2017 May 25.

PMID:
28622890
34.

Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain.

Fernández de Larrea-Baz N, Michel A, Romero B, Pérez-Gómez B, Moreno V, Martín V, Dierssen-Sotos T, Jiménez-Moleón JJ, Castilla J, Tardón A, Ruiz I, Peiró R, Tejada A, Chirlaque MD, Butt JA, Olmedo-Requena R, Gómez-Acebo I, Linares P, Boldo E, Castells A, Pawlita M, Castaño-Vinyals G, Kogevinas M, de Sanjosé S, Pollán M, Del Campo R, Waterboer T, Aragonés N.

Front Microbiol. 2017 May 29;8:888. doi: 10.3389/fmicb.2017.00888. eCollection 2017.

35.

Preanalytical Stability of Antibodies to Pathogenic Antigens.

Hodgkinson VS, Egger S, Betsou F, Waterboer T, Pawlita M, Michel A, Baker MS, Banks E, Sitas F.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1337-1344. doi: 10.1158/1055-9965.EPI-17-0170. Epub 2017 May 8.

PMID:
28483968
36.

Serology of Streptococcus gallolyticus subspecies gallolyticus and its association with colorectal cancer and precursors.

Butt J, Werner S, Willhauck-Fleckenstein M, Michel A, Waterboer T, Zörnig I, Boleij A, Dramsi S, Brenner H, Pawlita M.

Int J Cancer. 2017 Sep 1;141(5):897-904. doi: 10.1002/ijc.30765. Epub 2017 Jun 5.

PMID:
28477334
37.

A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.

Wang T, Cai H, Zheng W, Michel A, Pawlita M, Milne G, Xiang YB, Gao YT, Li HL, Rothman N, Lan Q, Shu XO, Epplein M.

Clin Infect Dis. 2017 May 15;64(10):1380-1386. doi: 10.1093/cid/cix106.

38.

Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.

Kreimer AR, Johansson M, Yanik EL, Katki HA, Check DP, Lang Kuhs KA, Willhauck-Fleckenstein M, Holzinger D, Hildesheim A, Pfeiffer R, Williams C, Freedman ND, Huang WY, Purdue MP, Michel A, Pawlita M, Brennan P, Waterboer T.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx005.

39.

Human papillomavirus 16 is an aetiological factor of scrotal cancer.

Guimerà N, Alemany L, Halec G, Pawlita M, Wain GV, Vailén JSS, Azike JE, Jenkins D, de Sanjosé S, Quint W, Bosch FX.

Br J Cancer. 2017 Apr 25;116(9):1218-1222. doi: 10.1038/bjc.2017.74. Epub 2017 Apr 4.

40.

Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.

Gheit T, Anantharaman D, Holzinger D, Alemany L, Tous S, Lucas E, Prabhu PR, Pawlita M, Ridder R, Rehm S, Bogers J, Maffini F, Chiocca S, Lloveras B, Kumar RV, Somanathan T, de Sanjosé S, Castellsagué X, Arbyn M, Brennan P, Sankaranarayanan R, Pillai MR, Gangane N, Tommasino M; HPV-AHEAD study group.

Int J Cancer. 2017 Jul 1;141(1):143-151. doi: 10.1002/ijc.30712. Epub 2017 Apr 19.

41.

Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.

Schroeder L, Boscolo-Rizzo P, Dal Cin E, Romeo S, Baboci L, Dyckhoff G, Hess J, Lucena-Porcel C, Byl A, Becker N, Alemany L, Castellsagué X, Quer M, León X, Wiesenfarth M, Pawlita M, Holzinger D.

Eur J Cancer. 2017 Mar;74:73-81. doi: 10.1016/j.ejca.2016.12.020. Epub 2017 Feb 10.

PMID:
28335889
42.

Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.

Holzinger D, Wichmann G, Baboci L, Michel A, Höfler D, Wiesenfarth M, Schroeder L, Boscolo-Rizzo P, Herold-Mende C, Dyckhoff G, Boehm A, Del Mistro A, Bosch FX, Dietz A, Pawlita M, Waterboer T.

Int J Cancer. 2017 Jun 15;140(12):2748-2757. doi: 10.1002/ijc.30697. Epub 2017 Apr 4.

43.

Autophagy regulates UBC9 levels during viral-mediated tumorigenesis.

Mattoscio D, Casadio C, Miccolo C, Maffini F, Raimondi A, Tacchetti C, Gheit T, Tagliabue M, Galimberti VE, De Lorenzi F, Pawlita M, Chiesa F, Ansarin M, Tommasino M, Chiocca S.

PLoS Pathog. 2017 Mar 2;13(3):e1006262. doi: 10.1371/journal.ppat.1006262. eCollection 2017 Mar.

44.

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection.

Beachler DC, Waterboer T, Pierce Campbell ChM, Ingles DJ, Kuhs KA, Nyitray AG, Hildesheim A, Pawlita M, Kreimer AR, Giuliano AR.

Papillomavirus Res. 2016 Dec;2:141-144. doi: 10.1016/j.pvr.2016.07.003. Epub 2016 Jul 28.

45.

Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines.

Albano PM, Holzinger D, Salvador C, Orosa J 3rd, Racelis S, Leaño M, Sanchez D Jr, Angeles LM, Halec G, Schmitt M, Ramos JD, Pawlita M.

PLoS One. 2017 Feb 15;12(2):e0172240. doi: 10.1371/journal.pone.0172240. eCollection 2017.

46.

Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa.

Clifford GM, Waterboer T, Dondog B, Qiao YL, Kordzaia D, Hammouda D, Keita N, Khodakarami N, Raza SA, Sherpa AT, Zatonski W, Pawlita M, Plummer M, Franceschi S.

Infect Agent Cancer. 2017 Feb 2;12:9. doi: 10.1186/s13027-017-0121-1. eCollection 2017.

47.

Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy.

Lupato V, Holzinger D, Höfler D, Menegaldo A, Giorgi Rossi P, Del Mistro A, Da Mosto MC, Pawlita M, Boscolo-Rizzo P.

PLoS One. 2017 Jan 19;12(1):e0170091. doi: 10.1371/journal.pone.0170091. eCollection 2017.

48.

Biological relevance of human papillomaviruses in vulvar cancer.

Halec G, Alemany L, Quiros B, Clavero O, Höfler D, Alejo M, Quint W, Pawlita M, Bosch FX, de Sanjose S.

Mod Pathol. 2017 Apr;30(4):549-562. doi: 10.1038/modpathol.2016.197. Epub 2017 Jan 6.

49.

Immune Response to HPV16 E6 and E7 Proteins and Patient Outcomes in Head and Neck Cancer.

Nelson HH, Pawlita M, Michaud DS, McClean M, Langevin SM, Eliot MN, Kelsey KT.

JAMA Oncol. 2016 Dec 8. doi: 10.1001/jamaoncol.2016.4500. [Epub ahead of print]

PMID:
27930753
50.

Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.

Rahman S, Pierce Campbell CM, Rollison DE, Wang W, Waterboer T, Michel A, Pawlita M, Villa LL, Lazcano Ponce E, Borenstein AR, Giuliano AR.

PLoS One. 2016 Nov 30;11(11):e0167173. doi: 10.1371/journal.pone.0167173. eCollection 2016.

Supplemental Content

Loading ...
Support Center